A pilot study discovered that the FSHR Ser680Asn genotype does not influence the follicular fluid hormonal profile or ovulation outcomes in cycles stimulated with varying gonadotropin preparations. The research, involving 40 women undergoing ART, compared two genetic variants and determined no significant impact on treatment results.
Read More
Real Madrid Threatens Boycott Over LaLiga's Heavy Fixture Schedule and 72-Hour Rest Rule
Valentine's Day: A Father's Farewell Brings New Perspectives on Sacrificial Love
Arsenal Looks to Overcome Injuries in Crucial Premier League Clash Against Ipswich Town
Roma's Summer Shake-Up: Houssem Aouar Among Potential Departures Amidst Major Squad Overhaul
France Actively Supports UN Resolution 1540 to Prevent Weapon Proliferation
